Posted inEPFO EPFO members can now avail second non-refundable COVID-19 advance by CS SURBHI SAXENA May 31, 2021May 31, 2021
Posted inTC Major social security relief to dependents of workers passing away due to COVID-19 announced by CS SURBHI SAXENA May 30, 2021
Posted inTC Government announces further measures to help families who lost the earning member due to Covid by CS SURBHI SAXENA May 29, 2021May 29, 2021
Posted inTC PM CARES For Children- Empowerment of COVID Affected Children launched by CS SURBHI SAXENA May 29, 2021
Posted inBUSINESS & ECONOMY Khadi and Village Industries Commission (KVIC) has bagged government purchase orders worth over Rs. 45 crore by CS SURBHI SAXENA May 29, 2021
Posted inTC National Environmental Engineering Research Institute (NEERI) develops Innovative Patient-Friendly Saline Gargle RT-PCR Testing Method by CS SURBHI SAXENA May 28, 2021
Posted inTC DST supported disinfection system makes N95 Masks, PPE, medical gear reusable and reduces excessive COVID 19 bio-medical waste generation by CS SURBHI SAXENA May 27, 2021
Posted inTC NITI Aayog and Chair of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) Dr Vinod Paul addresses Myths & Facts on India’s Vaccination Process by CS SURBHI SAXENA May 27, 2021
Posted inTC On-site Registration/Facilitated Cohort Registration in addition to Online Appointment for 18-44 years age group now Enabled on CoWIN by CS SURBHI SAXENA May 24, 2021
Posted inTC Delhi Lockdown extended till 31st May, 2021 : Delhi Govt. by CS LALIT RAJPUT May 23, 2021
Posted inTC Countrywide “AYUSH COVID -19 Counselling Helpline” operationalized by CS SURBHI SAXENA May 21, 2021
Posted inTC Principal Scientific Adviser to the Government of India releases Advisory on “Stop the Transmission, Crush the Pandemic – Masks, distance, sanitation and ventilation to prevent the spread of SARS-CoV-2 virus” by CS SURBHI SAXENA May 20, 2021
Posted inTC New Recommendations of National Expert Group on Vaccine Administration for Covid-19 accepted by Union Ministry of Health by CS SURBHI SAXENA May 19, 2021
Posted inTC Department of Science and Technology institute develops new multiplex RT-PCR kit with novel gene targets to facilitate detection across various mutant strains of COVID 19 by CS SURBHI SAXENA May 18, 2021
Posted inTC Team Tax Concept’s Initiative to Help India to Overcome Second Wave of COVID-19 Pandemic May 18, 2021
Posted inTC Children impacted by Covid-19 Pandemic being provided Tele Counselling through SAMVEDNA by CS SURBHI SAXENA May 17, 2021
Posted inTC Bleeding and clotting events following COVID vaccination miniscule in India by CS SURBHI SAXENA May 17, 2021
Posted inTC Defence Minister Shri Rajnath Singh unveils first batch of anti-COVID drug developed by DRDO by CS SURBHI SAXENA May 17, 2021
Posted inGST Compilation of Reliefs Provided in GST Compliance as well as GST Payment in the Wake of Second Wave of COVID-19 May 17, 2021May 17, 2021
Posted inTC Centre directs States to prevent dumping of dead bodies in Ganga and focus on their safe disposal by CS SURBHI SAXENA May 16, 2021
Posted inBUSINESS & ECONOMY No One shall be Denied Vaccine, Medicine, Hospitalization or Treatment for Want of Aadhaar: UIDAI May 16, 2021May 16, 2021
Posted inTC Department of Science and Technology supported startup develops affordable test kits for early diagnosis of Covid-19 by CS SURBHI SAXENA May 15, 2021
Posted inTC NHPC Ltd provides Cold Chain Equipment for Covid-19 Vaccination to Government of Arunachal Pradesh by CS SURBHI SAXENA May 15, 2021
Posted inTC Government Supports Augmentation of Manufacturing Capacity for COVAXIN production under Mission COVID Suraksha by CS SURBHI SAXENA May 15, 2021
Posted inTC Mega make-shift COVID centre set up at Kochi Refinery premises by CS SURBHI SAXENA May 14, 2021
Posted inBUSINESS & ECONOMY Relaxation in procurement rules for containment of COVID-19 pandemic by CS SURBHI SAXENA May 14, 2021
Posted inTC Mucormycosis – a Fungal Complication being Detected in COVID-19 Patients by CS SURBHI SAXENA May 14, 2021
Posted inTC Gap between two doses of Covishield Vaccine extended from 6-8 weeks to 12-16 weeks by CS SURBHI SAXENA May 13, 2021May 13, 2021
Posted inTC DCGI approves Phase 2 and 3 clinical trial of COVAXIN in the age group of 2 to 18 Years by CS SURBHI SAXENA May 13, 2021
